Evidence map›Paper›PMID 32764593›Full record

ArticleScientific reports2020

Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe.

M Mena, J Frias-Gomez, M Taberna, B Quirós, S Marquez, O Clavero, A Baena, B Lloveras, M Alejo, X León and 12 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. SEOM-TTCC clinical guidelines for the treatment of head and neck cancer (2025).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Guideline
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. HPV in oropharyngeal squamous papillomas: a missing link in head and neck viral pathogenesis.Virchows Archiv : an international journal of pathology · 2026
    Article
  7. A population-based study of incidence trends of head and neck epithelial cancers in northeastern Spain, 1994-2018.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Epidemiology of HPV Related Malignancies.Seminars in radiation oncology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 1 country.

M Mena *Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain. mmena@iconcologia.net.
J Frias-Gomez *Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.
M TabernaCancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.
B QuirósCancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.
S MarquezCancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.
O ClaveroCancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.
A BaenaTobacco Control Unit, WHO Collaborating Centre for Tobacco Control, ICO, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
B LloverasDepartment of Pathology, Hospital del Mar, Barcelona, Spain.
M AlejoDepartment of Pathology, Hospital General de L'Hospitalet, Barcelona, Spain.
X LeónDepartment of Otorhinolaryngology, Hospital de Sant Pau, Barcelona, Spain.
J GarcíaDepartment of Otorhinolaryngology, Hospital de Sant Pau, Barcelona, Spain.
R MesíaDepartment of Medical Oncology, ICO, B-ARGO Group, Badalona, Barcelona, Spain.
O BermejoDepartment of Plastic Surgery, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
T BonfillDepartment of Medical Oncology, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain.
A AguilaDepartment of Otorhinolaryngology, Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain.
M GuixDepartment of Medical Oncology, Hospital del Mar, Barcelona, Spain.
R HijanoDepartment of Otorhinolaryngology, Hospital del Mar, Barcelona, Spain.
M A PavónCancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.
M TorresCancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.
S TousCancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain.
R ClèriesPla Director d'Oncologia, ICO, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
L AlemanyCancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Av. Gran Via de L'Hospitalet 199-203, 08908, Barcelona, Spain. lalemany@iconcologia.net.
Institut Català d'Oncologia · ESInstitut d'Investigació Biomédica de Bellvitge · ESHospital Del Mar · ESCorporació Sanitària Parc Taulí · ESHospital de Sant Pau · ESUniversitat de Barcelona · ESBellvitge University Hospital · ESHospital General de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of human papillomavirus (HPV)-related oropharyngeal cancer is increasing in some regions. Nevertheless, the epidemiology of this disease has not been extensively investigated in southern Europe. We conducted a retrospective cohort study of patients diagnosed with primary oropharyngeal cancer from 1991 to 2016. Cancer tissues underwent histopathological evaluation, DNA quality control, HPV-DNA detection and p16

Indexed as

AlphapapillomavirusAdultAgedAged, 80 and overCohort StudiesEuropeFemaleHumansMaleMiddle AgedOropharyngeal NeoplasmsPapillomavirus InfectionsPrevalenceRetrospective Studies

Identifiers

PMID32764593
PMCPMC7411067
OpenAlexW3047293503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.